Loading viewer...
investor_presentation
Format: PDF investor_presentation
Verrica Pharmaceuticals presents company overview highlighting the FDA approval of YCANTH™, the first FDA-approved treatment for molluscum contagiosum. The presentation covers Verrica's business strategy, clinical programs, and commercial launch plans for its lead product candidate.
investor_presentation
43 Pages
JSW Steel